Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy
Natural killer (NK) cells have recently gained popularity as an alternative for cancer immunotherapy. Adoptive cell transfer employing NK cells offers a safer therapeutic option compared to T-cell-based therapies, due to their significantly lower toxicity and the availability of diverse autologous a...
Saved in:
Main Authors: | Stefania Douka (Author), Vasilis Papamoschou (Author), Monica Raimo (Author), Enrico Mastrobattista (Author), Massimiliano Caiazzo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing Memory NK Cell to Protect Against COVID-19
by: Saeede Soleimanian, et al.
Published: (2020) -
Harnessing the power within: engineering the microbiome for enhanced gynecologic health
by: Caitriona Brennan, et al.
Published: (2024) -
NK Cell-Based Cancer Immunotherapy
by: Susana Larrucea
Published: (2016) -
Investigating and harnessing T-cell functions with engineered immune receptors and their ligands
by: Bruno Laugel
Published: (2015) -
Chasing Uterine Cancer with NK Cell-Based Immunotherapies
by: Vijay Kumar, et al.
Published: (2022)